Department of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Materials Engineering Division/Non-destructive Evaluation Group, Livermore National Laboratory, Livermore, CA, 94550, USA.
J Appl Clin Med Phys. 2021 May;22(5):97-109. doi: 10.1002/acm2.13198. Epub 2021 May 3.
The purpose of this work was to estimate and compare breast and lung doses of chest CT scans using organ-based tube current modulation (OBTCM) to those from conventional, attenuation-based automatic tube current modulation (ATCM) across a range of patient sizes.
Thirty-four patients (17 females, 17 males) who underwent clinically indicated CT chest/abdomen/pelvis (CAP) examinations employing OBTCM were collected from two multi-detector row CT scanners. Patient size metric was assessed as water equivalent diameter (D ) taken at the center of the scan volume. Breast and lung tissues were segmented from patient image data to create voxelized models for use in a Monte Carlo transport code. The OBTCM schemes for the chest portion were extracted from the raw projection data. ATCM schemes were estimated using a recently developed method. Breast and lung doses for each TCM scenario were estimated for each patient model. CTDI -normalized breast (nD ) and lung (nD ) doses were subsequently calculated. The differences between OBTCM and ATCM normalized organ dose estimates were tested using linear regression models that included CT scanner and D as covariates.
Mean dose reduction from OBTCM in nD was significant after adjusting for the scanner models and patient size (P = 0.047). When pooled with females and male patient, mean dose reduction from OBTCM in nD was observed to be trending after adjusting for the scanner model and patient size (P = 0.085).
One specific manufacturer's OBTCM was analyzed. OBTCM was observed to significantly decrease normalized breast relative to a modeled version of that same manufacturer's ATCM scheme. However, significant dose savings were not observed in lung dose over all. Results from this study support the use of OBTCM chest protocols for females only.
本研究旨在估算并比较使用基于器官的管电流调制(OBTCM)与基于衰减的自动管电流调制(ATCM)的胸部 CT 扫描的乳腺和肺剂量,比较范围涵盖多种患者体型。
从两台多排 CT 扫描仪中收集了 34 名接受临床指征胸部/腹部/骨盆 CT(CAP)检查的患者(17 名女性,17 名男性)。患者体型指标采用扫描体积中心处的水等效直径(D)进行评估。从患者图像数据中分割出乳腺和肺组织,以创建用于蒙特卡罗传输代码的体素化模型。从原始投影数据中提取了胸部部分的 OBTCM 方案。使用最近开发的方法估计了 ATCM 方案。为每个患者模型估算了每个 TCM 方案的乳腺和肺剂量。随后计算了 CTDI 归一化乳腺(nD)和肺(nD)剂量。使用包含 CT 扫描仪和 D 作为协变量的线性回归模型测试了 OBTCM 和 ATCM 归一化器官剂量估计之间的差异。
调整了扫描仪模型和患者体型后,OBTCM 方案的 nD 平均剂量降低具有统计学意义(P = 0.047)。当合并女性和男性患者数据时,调整了扫描仪模型和患者体型后,OBTCM 方案的 nD 平均剂量降低呈趋势(P = 0.085)。
分析了一个特定制造商的 OBTCM。OBTCM 与同一制造商的 ATCM 模型相比,显著降低了归一化乳腺的相对剂量。然而,在所有情况下,肺剂量并未显著降低。本研究结果支持仅在女性中使用 OBTCM 胸部协议。